Skip to main content
Toggle navigation
Login
Home
iwCLL X / Twitter
Favorite
Tweet
Agnieszka Chudy, MSc, PhD
Laboratory of Genetics, University Clinical Centre of Medical University of Warsaw, Poland, Poland
Poster(s):
1423 - MRD-Driven Venetoclax and Rituximab Combination in Previously Untreated Chronic Lymphocytic Leukemia: Results of the Prospective, Multicenter, Phase II Trial of the Polish Adult Leukemia Group (VERITA PALG-CLL5)
LB05 - Integrated immunogenetic and cytogenetic profiling reveals distinct biological patterns among stereotyped BCR subsets in CLL